GREGORY SARGEN

Insider Reports History

Signature
/s/ Mary Grendell, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by GREGORY SARGEN:

Company Role Class Num Shares Value Price $ Report Date Ownership
Avid Bioservices, Inc. Director Common Stock, $0.001 par value 0 $0 $12.37 05 Feb 2025 Direct
Avid Bioservices, Inc. Director Restricted Stock Units 0 $0 $12.37 05 Feb 2025 Direct
Protara Therapeutics, Inc. Director Stock Option (Right to Buy) 24,000 12 Jun 2025 Direct
Avid Bioservices, Inc. Director Stock Option (right to buy) 0 05 Feb 2025 Direct

Insider Reports Filed by GREGORY SARGEN

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TARA Protara Therapeutics, Inc. 12 Jun 2025 1 $0 4 Director 13 Jun 2025, 16:05
CDMO Avid Bioservices, Inc. 05 Feb 2025 6 $0 4 Director 07 Feb 2025, 19:39
CDMO Avid Bioservices, Inc. 14 Dec 2024 3 $0 4 Director 17 Dec 2024, 19:49
TARA Protara Therapeutics, Inc. 07 Jun 2024 1 $0 4 Director 10 Jun 2024, 18:00
CDMO Avid Bioservices, Inc. 14 Dec 2023 3 $0 4 Director 18 Dec 2023, 19:33
TARA Protara Therapeutics, Inc. 07 Jun 2023 1 $0 4 Director 08 Jun 2023, 16:10
CDMO Avid Bioservices, Inc. 11 Apr 2023 1 -$141,919 4 Director 12 Apr 2023, 19:34
CDMO Avid Bioservices, Inc. 14 Dec 2022 3 $0 4 Director 16 Dec 2022, 19:01
TARA Protara Therapeutics, Inc. 08 Jun 2022 1 $0 4 Director 09 Jun 2022, 16:10
CDMO Avid Bioservices, Inc. 14 Dec 2021 3 $0 4 Director 16 Dec 2021, 20:34
TARA Protara Therapeutics, Inc. 09 Jun 2021 1 $0 4 Director 10 Jun 2021, 20:07